Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Butler, J. Ahronheim, H. Fillit, S. Rapoport, T. Tatemichi (1993)
Vascular dementia: how to make the diagnosis in office practice.Geriatrics, 48 12
K. Davis, L. Thal, E. Gamzu, C. Davis, R. Woolson, S. Gracon, D. Drachman, L. Schneider, P. Whitehouse, T. Hoover, J. Morris, C. Kawas, D. Knopman, N. Earl, Vinod Kumar, R. Doody (1992)
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.The New England journal of medicine, 327 18
E. Chiu, D. Ames (1990)
Depression in the elderly.Australian family physician, 19 9
D. Evans, H. Funkenstein, M. Albert, P. Scherr, P. Scherr, N. Cook, M. Chown, L. Hebert, C. Hennekens, James Taylor (1989)
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.JAMA, 262 18
S. Katz, T. Downs, H. Cash, R. Grotz (1970)
Progress in development of the index of ADL.The Gerontologist, 10 1
C. Kügler (1996)
THE P300 AND VASCULAR DEMENTIA: NOT QUITE READY FOR PRIME TIMEJournal of the American Geriatrics Society, 44
E. Kokmen, K. Offord, H. Okazaki (1987)
A clinical and autopsy study of dementia in Olmsted County, Minnesota, 1980–1981Neurology, 37
M. Folstein, M. Folstein, S. Folstein, S. Folstein, P. McHugh, P. McHugh (1975)
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 12
G. Zoppo (1988)
Thrombolytic therapy in cerebrovascular disease.Stroke, 19
(1993)
Prevalence and treatment of vascular demen
F. Forette, T. Hoover, S. Gracon, J. Rotrou, M. Hervy, B. Lechevalier, M. Micas, H. Petit, J. Orgogozo, O. Guard, D. Saudeau, B. Forette, B. Michel, J. Emile, P. Augustin, A. Wang, J. Vignat, H. Allain, G. Cuny, J. Léger, M. Collard, O. Joyeux, R. Khalil (1995)
A double‐blind, placebo‐controlled, enriched population study of tacrine in patients with Alzheimer's diseaseEuropean Journal of Neurology, 2
J. Sheikh, J. Yesavage (1986)
Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.Clinical Gerontologist, 5
S. Katz, C. Akpom (1976)
A Measure of Primary Sociobiological FunctionsInternational Journal of Health Services, 6
J. Brust (1993)
Vascular Dementia ReconsideredCerebrovascular Diseases, 3
B. Reisberg, S. Ferris, M. Leon, T. Crook (1982)
The Global Deterioration Scale for assessment of primary degenerative dementia.The American journal of psychiatry, 139 9
D. Singer, R. Hughes, D. Gress, M. Sheehan, L. Oertel, S. Maraventano, D. Blewett, B. Rosner, J. Kistler (1990)
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.The New England journal of medicine, 323 22
F. Manning (1994)
Tacrine therapy for the dementia of Alzheimer's disease.American family physician, 50 4
N. Meiran, D. Stuss, D. Guzman, G. Laflèche, J. Willmer (1996)
Diagnosis of dementia. Methods for interpretation of scores of 5 neuropsychological tests.Archives of neurology, 53 10
L. Wilkins (1994)
National High Blood Pressure Education Program Working Group Report on Hypertension in the ElderlyHypertension, 23
C. Loeb, C. Gandolfo, C. Loeb (1983)
Diagnostic evaluation of degenerative and vascular dementia.Stroke, 14
M. Tabaton (1994)
Research advances in the biology of Alzheimer's disease.Clinics in geriatric medicine, 10 2
M. O'brien (1986)
Cerebral blood flow in dementiaNeurology, 36
M. Folstein, L. Robins, J. Helzer (1983)
The Mini-Mental State Examination.Archives of general psychiatry, 40 7
C. Lyketsos, K. Corazzini, C. Steele, M. Kraus (1996)
Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.The Journal of neuropsychiatry and clinical neurosciences, 8 1
W. Rosen, R. Mohs, K. Davis (1984)
A new rating scale for Alzheimer's disease.The American journal of psychiatry, 141 11
N. Foster, Ronald Petersen, Ronald Petersen, S. Gracon, K. Lewis (1996)
An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group.Dementia, 7 5
M. Folstein, J. Anthony, Irma Parhad, Bonnie Duffy, E. Gruenberg (1985)
The Meaning of Cognitive Impairment in the ElderlyJournal of the American Geriatrics Society, 33
Jerome Yesavage, T. Brink, Terrence Rose, Owen Lum, T. Huang, Hb Adey, V. Leirer (1983)
Development and validation of a geriatric depression rating scale: a preliminary report
J. Meyer, B. Judd, T. Tawaklna, R. Rogers, K. Mortel (1986)
Improved cognition after control of risk factors for multi-infarct dementia.JAMA, 256 16
(1997)
Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association.The American journal of psychiatry, 154 5 Suppl
J. Shua-haim, Erica Comsti, Vered Shua-Haim, J. Ross (1997)
Donepezil (AriceptTM): The caregivers voice and clinical impressionAmerican Journal of Alzheimer's Disease and Other Dementias, 12
M. Farlow, S. Gracon, L. Hershey, K. Lewis, C. Sadowsky, Jann Dolan-Ureno (1992)
A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.JAMA, 268 18
J. Morris (1996)
Classification of dementia and Alzheimer's diseaseActa Neurologica Scandinavica, 94
Sydney Katz (1983)
Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily LivingJournal of the American Geriatrics Society, 31
R. Butler, J. Ahronheim, H. Fillit, S. Rapoport, J. Tatemichi (1993)
Vascular dementia: stroke prevention takes on new urgency.Geriatrics, 48 11
A. Wallin, K. Blennow (1993)
Heterogeneity of Vascular Dementia: Mechanisms and SubgroupsJournal of Geriatric Psychiatry and Neurology, 6
E. Larson (1993)
Illnesses causing dementia in the very elderly.The New England journal of medicine, 328 3
M. Kotila, O. Waltimo, M. Niemi, R. Laaksonen (1986)
Dementia after stroke.European neurology, 25 2
M. Falkeborn, I. Persson, Andreas Terént, H. Adami, Hans Lithell, Reinhold Bergström (1993)
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.Archives of internal medicine, 153 10
J. Cummings, B. Miller, M. Hill, R. Neshkes (1987)
Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type.Archives of neurology, 44 4
J. Meyer, R. Rogers, Karen McClintic, K. Mortel, J. Lotfi (1989)
Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct DementiaJournal of the American Geriatrics Society, 37
V. Hachinski, N. Lassen, J. Marshall (1974)
Multi-infarct dementia. A cause of mental deterioration in the elderly.Lancet, 2 7874
W. Rosen, R. Terry, P. Fuld, R. Katzman, A. Peck (1980)
Pathological verification of ischemic score in differentiation of dementiasAnnals of Neurology, 7
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
J. Holstein, G. Chatellier, F. Piette, R. Moulias (1994)
Prevalence of Associated Diseases in Different Types of Dementia Among Elderly Institutionalized Patients: Analysis of 3447 RecordsJournal of the American Geriatrics Society, 42
John Rothrock, Robert Hart (1991)
Antithrombotic therapy in cerebrovascular disease.Annals of internal medicine, 115 11
Butler Rn, J. Ahronheim, H. Fillit, Rapoport Si, T. Tatemichi (1994)
Vascular dementia: an updated approach to patient management. A roundtable discussion: Part 3.Geriatrics, 49 1
P. Watkins, H. Zimmerman, M. Knapp, S. Gracon, K. Lewis (1994)
Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.JAMA, 271 13
Rocco Vivenzio (2001)
Geriatrics Review Syllabus: A Core Curriculum in Geriatric MedicineAnnals of Internal Medicine, 134
J. Cummings (1988)
Depression in vascular dementia.The Hillside journal of clinical psychiatry, 10 2
M. Knapp, D. Knopman, P. Solomon, W. Pendlebury, C. Davis, S. Gracon, J. Apter, Clifford Lazarus, Karen Baker, M. Barnett, B. Baumel, L. Eisner, D. Bennett, C. Forchetti, A. Levin, J. Blass, K. Nolan, E. Gaines, N. Relkin, R. Borison, B. Diamond, G. Celesia, A. Ross, J. Dexter, R. Doody, L. Lipscomb, Kurt Kreiter, E. Duboff, P. Block, D. Marshall, Nancy Westergaard, N. Earl, S. Wyne, Elisabeth Hinman-Smith, M. Farlow, H. Hendrie, Judith Caress, M. Farmer, J. Harper, J. Ferguson, N. Foster, N. Barbas, L. Bluemlein, D. Gelb, S. Berent, B. Giordani, M. Greenwald, S. Bergman, L. Roger, A. Groenendyk, M. Wood, C. Jurkowski, I. Katz, Suzanne Doyle, Buster Smith, C. Kellner, H. Bernstein, D. Bachman, S. Deinard, L. Langley, Sarah Bridges, R. Margolin, M. Burger, S. Wiser, C. Crenshaw, J. Morris, E. Rubin, M. Coats, P. Reyes, Catherine Bentz, Lara Doyle, M. Rymer, I. Bettinger, M. Laubinger, C. Sadowsky, Walter Martínez, J. Zúñiga, R. Stone, P. Winner, L. Maté, Carla Lessard, L. Schneider, S. Pawluczyk, Ward Smith, Scott Losk, Linda Marambe, M. Groccia-Ellison, K. Edwards, John Taylor, V. Calabrese, S. Harkins, S. Thein, J. Dewar, G. Williams, C. Drennan, Paul Tuttle, N. Principi, E. Ford, Robert Tyndall, C. Kelley (1994)
A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's DiseaseJAMA, 271
J. Anthony, L. Leresche, Unaiza Niaz, M. Korff, M. Folstein (1982)
Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patientsPsychological Medicine, 12
M. Lawton, M. Moss, M. Fulcomer, M. Kleban (1982)
A research and service oriented multilevel assessment instrument.Journal of gerontology, 37 1
S. Rogers, L. Friedhoff (1996)
The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trialDementia, 7
O. Lopez, M. Larumbe, J. Becker, D. Rezek, J. Rosen, W. Klunk, S. DeKosky (1994)
Reliability of NINDS‐AIREN clinical criteria for the diagnosis of vascular dementiaNeurology, 44
V. Hachinski, J. Bowler, C. Loeb (1993)
Vascular dementiaNeurology, 43
Y. Kitagawa, J. Meyer, K. Mortel, R. Rogers (1984)
CT-CBF Correlations of Cognitive Deficits in Multi-Infarct DementiaStroke, 15
R. Dustman, R. Ruhling, Ewan Russell, D. Shearer, H. Bonekat, J. Shigeoka, J. Wood, D. Bradford (1984)
Aerobic exercise training and improved neuropsychological function of older individualsNeurobiology of Aging, 5
A. Rosen, S. Mukherjee, S. Olarte, V. Varia, C. Cárdenas (1982)
Dr. Rosen and Associates ReplyAmerican Journal of Psychiatry, 139
A. Burns, B. Tomlinson, D. Mann (1997)
Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356International Journal of Geriatric Psychiatry, 12
J. Reuck, G. Sieben, W. Coster, H. eecken (1982)
Dementia and confusional state in patients with cerebral infarcts. A clinicopathological study.European neurology, 21 2
K. Mortel, M. Pavol, S. Wood, J. Meyer, Y. Terayama, J. Rexer, Brian Herod (1994)
Prospective Studies of Cerebral Perfusion and Cognitive Testing Among Elderly Normal Volunteers and Patients with Ischemic Vascular Dementia and Alzheimer's DiseaseAngiology, 45
J. Monfort (1993)
A population-based study of dementia in 85-year-olds.The New England journal of medicine, 329 1
V. Hachinski (1992)
Preventable senility: a call for action against the vascular dementiasThe Lancet, 340
(1996)
E2020 produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer’s disease: Results of a 30-week phase III trial
H. Chui, J. Victoroff, D. Margolin, W. Jagust, R. Shankle, R. Katzman (1992)
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 42
M. Lawton (1988)
Scales to measure competence in everyday activities.Psychopharmacology bulletin, 24 4
C. Kase (1986)
“Multi‐infarct” Dementia: A Real Entity?Journal of the American Geriatrics Society, 34
R. Siman, Bary Greenberg (1986)
Alzheimer's disease.The New England journal of medicine, 314 15
M. Reding, J. Haycox, J. Blass (1985)
Depression in patients referred to a dementia clinic. A three-year prospective study.Archives of neurology, 42 9
The purpose of this study was to investigate the clinical and caregivers impression of Aricept ® treatment in patients suffering from Multi-Infarct Dementia (MID). In a prospective study 73 MID patients1 were treated with Donepezil (Aricept®) for 16-to 20-weeks. Donepezil was administered as a 5mg tablet once daily at bedtime. After four weeks, patients tolerant of the 5-mg dose were increased to 10 mg daily. All patients satisfied the DSM-III-R criteria for Multi-Infarct Dementia.2After 16-to 20-weeks of treatment, the patient's caregiver completed a questionnaire concerning the effectiveness of the drug. Subjective cognitive improvement, MMSE,3 ADL4 and IADL5 outcomes were all assessed before and after treatment (referred to as Clinical Impression). Behavioral outcomes evaluated included depression, agitation, violence, anxiety, and paranoid thoughts. Functional and overall family satisfaction were also evaluated. Side effects as well as reasons for discontinuation from the study were also reported. Seventy-three patients participated in the study. Twelve patients (16 percent) terminated participation due to side effects. Total adverse events were reported in 34 (46.5 percent) of patients. Cognitive improvement was reported in 31 (42.4 percent) patients. Verbal skills and attention were the most commonly reported cognitive improvement. Average MMSE declined by 2.6 points after 16-weeks of treatment. No behavioral improvement was reported. Behavioral deterioration was reported in 16 (21.9 percent) of patients. Functional improvement was reported in 32 (42.8 percent) patients. Overall positive family satisfaction was reported in 54 (73.9 percent) patients. Although Donepezil treatment was approved by the FDA for the treatment of Alzheimer's Disease (AD), such treatment for MID patients appears to be a reasonably safe and effective treatment from the caregiver and family's point of view.
American Journal of Alzheimer's Disease – SAGE
Published: Sep 4, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.